Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!

Alex Schroeder

"Marketplace Morning Report" Producer

SHORT BIO

Alex is a producer for the “Marketplace Morning Report.” He's based in Queens, New York.

Alex joined Marketplace in 2020, working as MMR's digital producer. After a little over a year, he became the show's overnight producer, getting up far before the crack of dawn to put together the day's newscasts with the host and team. Now, he works daylight hours, preparing interviews for the following morning and producing long-term specials and series.

Before Marketplace, Alex worked on several national public radio shows produced out of WBUR in Boston. He was both a radio and digital producer with “On Point,” “Here & Now” and “Only a Game.” Alex also worked at The Boston Globe after graduating from Tufts University.

Alex's interests outside of work tend to fall into one of two categories: film or soccer. (Come on Arsenal!) He’s always looking for ways to cover the economics of entertainment and sports on the “Marketplace Morning Report.”

Latest Stories (405)

Lapse in Fed lending programs could cost companies hurt by COVID

Companies hurt by the pandemic could end up paying investors a full percentage point more in interest to buy their bonds.
Treasury Secretary Steven Mnuchin and Chairman of the Federal Reserve Jerome Powell testify during the Senate's Committee on Banking, Housing, and Urban Affairs hearing examining the quarterly CARES Act report to Congress on Sept. 24, 2020, in Washington.
Drew Angerer/Pool/AFP via Getty Images

Oxford-AstraZeneca vaccine may pose fewer distribution challenges

That would be an advantage particularly for getting a COVID-19 vaccine to developing countries.
An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on Nov. 17, 2020.
Justin Tallis/AFP via Getty Images

Mnuchin moves to cut off Fed pandemic emergency lending program

Economist Karen Petrou says the Fed programs have fallen short, but that the Fed needs some facilities in the face of inaction from Congress.
Treasury Secretary Steven Mnuchin and Federal Reserve Board Chair Jerome Powell testify during a Senate Banking Committee hearing on Capitol Hill on Sept. 24, 2020 in Washington.
Drew Angerer/Getty Images

Pfizer to ask today for emergency vaccine authorization

Emergency authorization means the FDA facilitates availability of the vaccine during a declared state of emergency.
An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes with the logo of pharmaceutical company Pfizer, on Nov. 17, 2020.
Justin Tallis/AFP via Getty Images

Senate blocks Trump Fed nominee Judy Shelton

It seems that Shelton's chances at joining the Federal Reserve’s Board of Governors are narrowing.
Judy Shelton, nominee for the Federal Reserve's Board of Governors.
Sarah Silbiger/Getty Images

U.S. approves return of Boeing's 737 Max airplane

Airlines using Boeing's 737 Max will have to get FAA approval for pilot training programs and complete required maintenance.
The plane had been grounded after a pair of deadly crashes revealed design flaws and trouble in the air certification process.
Joe Raedle/Getty Images

China, Asia-Pacific countries sign deal to form world's biggest trading bloc

The China-backed Regional Comprehensive Economic Partnership forms the world’s largest trading bloc.
Vietnam's Prime Minister Nguyen Xuan Phuc (left) and Minister of Industry and Trade Tran Tuan Anh attend the signing ceremony for the Regional Comprehensive Economic Partnership (RCEP) trade pact at the ASEAN summit held online in Hanoi on Nov. 15, 2020.
Nhac Nguyen/AFP via Getty Images

Second coronavirus vaccine, from Moderna, shows promise

Pharmaceutical company Moderna said its vaccine appears to be 94.5% effective, according to preliminary data.
Maddie Meyer/Getty Images

Moderna says it can start analyzing how well its COVID-19 vaccine works

Moderna's clinical trial has accumulated sufficient data on volunteers with infections to analyze vaccine efficacy.
Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Fla., on Aug. 13, 2020.
Chandan Khanna/AFP via Getty Images

Big Tech isn't "home free" with Biden presidency, professor says

"I think Mr. Biden is less strident than Mr. Trump is. But Mr. Biden won't lay off a lot.," says Erik Gordon of the University of Michigan’s Ross School of Business.
President-elect Joe Biden waves to supporters as he leaves The Queen theater after receiving a briefing from the transition COVID-19 advisory board on Nov. 9, 2020 in Wilmington, Delaware.
Joe Raedle/Getty Images